Clinical study for PET microdose method by oral dose of [11C]Telmisartan in healthy volunteers.

Trial Profile

Clinical study for PET microdose method by oral dose of [11C]Telmisartan in healthy volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 16 May 2016

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Cardiovascular disorders; Essential hypertension; Hypertension; Metabolic syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Sep 2011 Status changed from active, no longer recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
    • 10 Aug 2011 Status changed from suspended to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 09 Aug 2011 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top